Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H10O |
Molecular Weight | 230.2607 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1C2=CC=CC=C2C3=CC=CC4=CC=CC1=C34
InChI
InChIKey=HUKPVYBUJRAUAG-UHFFFAOYSA-N
InChI=1S/C17H10O/c18-17-14-8-2-1-7-12(14)13-9-3-5-11-6-4-10-15(17)16(11)13/h1-10H
Molecular Formula | C17H10O |
Molecular Weight | 230.2607 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Benzanthrone (BA) is an important dye used in the manufacturing of several polycyclic vats and disperse dyes in textile industries. In several clinical studies, it has been shown that workers exposed to BA developed itching, burning sensation, erythema and hyperpigmentation of the skin, which could be an outcome of the dysregulated immune response. Chronically exposed workers complained loss of appetite, intolerance to fatty food, fatigue, weight loss, weakness and decrease in sexual activity. Recently was discovered, that benzanthrone binds to a critical component in the regulation of the BA-induced inflammation, Toll-like receptor 4, TLR4.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: O00206|||Q5VZI8 Gene ID: 7099.0 Gene Symbol: TLR4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/28495615 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Role of biological antioxidants in benzanthrone toxicity. | 2001 Jun |
|
Comparative effect of benzanthrone and 3-bromobenzanthrone on hepatic xenobiotic metabolism and anti-oxidative defense system in guinea pigs. | 2003 Feb |
|
Identification of estrogenic compounds emitted from the combustion of computer printed circuit boards in electronic waste. | 2007 Dec 15 |
|
Biochemical parameters of liver function in artisans occupationally exposed to "vat dyes". | 2007 May |
|
Concentration of oxygenated polycyclic aromatic hydrocarbons and oxygen free radical formation from urban particulate matter. | 2007 Nov |
|
Correlation of altered blood albumin characteristics and lymphocyte populations to tumor stage in gastrointestinal cancer patients. | 2010 |
|
Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs. | 2015 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25454808
immunotoxicity in Balb/c mice: benzanthrone (7.5mg/kgb.w. and 15mg/kgb.w.) for one week
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1880787
In vitro addition of benzanthrone caused a spectral change with oxidized microsomal cytochrome P450 (P450) and concentration-dependent reduction in the carbon monoxide spectrum of dithionite-reduced P450. The addition of benzanthrone to hepatic microsomes prepared from phenobarbital-treated rats resulted in spectral changes characterized by an absorbance maximum at 397 nm indicative of type I binding. In vitro addition of benzanthrone showed a concentration-dependent inhibition of hepatic aminopyrine N-demethylase (APD) and ethoxyresorufin-O-deethylase (ERD) activities with respective I50 values of 9.5 x 10(-4) and 8.0 x 10(-5) M. However, the inhibition of aryl hydrocarbon hydroxylase (AHH) even at the highest concentration of benzanthrone (10(-2) M), was of the order of only 29%.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:10:41 GMT 2023
by
admin
on
Fri Dec 15 17:10:41 GMT 2023
|
Record UNII |
LP5P3RR8QN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
631641
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
6697
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
5189
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
5245
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
C012768
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
m2335
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | Merck Index | ||
|
LP5P3RR8QN
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
Benzanthrone
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
201-393-3
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
DTXSID8052566
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY | |||
|
82-05-3
Created by
admin on Fri Dec 15 17:10:41 GMT 2023 , Edited by admin on Fri Dec 15 17:10:41 GMT 2023
|
PRIMARY |